statistiche ricercatore

Continente	#
NA - Nord America	870
AS - Asia	343
EU - Europa	208
SA - Sud America	41
AF - Africa	10
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.473

Nazione	#
US - Stati Uniti d'America	858
SG - Singapore	162
CN - Cina	63
VN - Vietnam	46
DE - Germania	41
BR - Brasile	32
RU - Federazione Russa	32
HK - Hong Kong	31
IT - Italia	24
GB - Regno Unito	22
FR - Francia	16
IN - India	16
UA - Ucraina	14
BE - Belgio	11
FI - Finlandia	11
CZ - Repubblica Ceca	8
CA - Canada	7
IE - Irlanda	7
ES - Italia	5
BD - Bangladesh	4
PL - Polonia	4
ZA - Sudafrica	4
AR - Argentina	3
JP - Giappone	3
LT - Lituania	3
SE - Svezia	3
AT - Austria	2
CO - Colombia	2
IQ - Iraq	2
IR - Iran	2
MA - Marocco	2
MX - Messico	2
PK - Pakistan	2
TN - Tunisia	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AZ - Azerbaigian	1
BO - Bolivia	1
EC - Ecuador	1
EG - Egitto	1
EU - Europa	1
GE - Georgia	1
GP - Guadalupe	1
GR - Grecia	1
HN - Honduras	1
ID - Indonesia	1
KR - Corea	1
LB - Libano	1
LV - Lettonia	1
MN - Mongolia	1
MZ - Mozambico	1
NL - Olanda	1
RO - Romania	1
SK - Slovacchia (Repubblica Slovacca)	1
SY - Repubblica araba siriana	1
TH - Thailandia	1
TJ - Tagikistan	1
TR - Turchia	1
TT - Trinidad e Tobago	1
UZ - Uzbekistan	1
Totale	1.473

Nome	#
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker	187
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression	172
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma	163
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma	152
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients	148
Serum markers as predictors of immune checkpoint inhibitors (ICI) related adverse events in a real-world scenario	123
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study	123
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis	118
Melanoma immunotherapy: strategies to overcome pharmacological resistance	85
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva	85
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study	84
Is chemotherapy worthwhile in patients with high-risk, lymph node negative, FIGO stage 1, endometrial cancer?	70
Totale	1.510

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	53	0	0	0	0	0	0	0	0	0	11	24	18
2021/2022	118	14	11	0	0	4	0	6	6	1	13	51	12
2022/2023	159	13	25	3	22	19	27	1	8	23	2	9	7
2023/2024	87	9	1	3	5	12	26	0	6	5	2	0	18
2024/2025	251	8	14	7	17	19	13	23	15	31	22	31	51
2025/2026	542	84	48	27	60	98	48	69	14	56	38	0	0
Totale													1.510